NewEdge Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.7M | Buy |
413,565
+17,134
| +4% | +$1.98M | 0.18% | 118 |
|
|
2025
Q4 | $41.7M | Buy |
396,431
+55,273
| +16% | +$5.19M | 0.15% | 133 |
|
|
2025
Q3 | $28.6M | Sell |
341,158
-25,231
| -7% | -$2.08M | 0.13% | 155 |
|
|
2025
Q2 | $29M | Sell |
366,389
-39,977
| -10% | -$3.18M | 0.15% | 134 |
|
|
2025
Q1 | $36.5M | Sell |
406,366
-4,357
| -1% | -$407K | 0.22% | 100 |
|
|
2024
Q4 | $40.9M | Buy |
410,723
+16,837
| +4% | +$1.74M | 0.25% | 83 |
|
|
2024
Q3 | $44.7M | Sell |
393,886
-261,688
| -40% | -$31.1M | 0.29% | 73 |
|
|
2024
Q2 | $81.2M | Buy |
655,574
+45,591
| +7% | +$5.87M | 0.59% | 25 |
|
|
2024
Q1 | $80.5M | Buy |
609,983
+19,644
| +3% | +$2.42M | 0.7% | 18 |
|
|
2023
Q4 | $66.1M | Buy |
590,339
+39,515
| +7% | +$4.1M | 0.63% | 20 |
|
|
2023
Q3 | $56.7M | Buy |
550,824
+22,909
| +4% | +$2.47M | 0.62% | 22 |
|
|
2023
Q2 | $60.9M | Sell |
527,915
-7,449
| -1% | -$846K | 0.69% | 15 |
|
|
2023
Q1 | $57.5M | Buy |
535,364
+8,483
| +2% | +$916K | 0.72% | 15 |
|
|
2022
Q4 | $17.9M | Buy |
526,881
+45,732
| +10% | +$4.67M | 0.48% | 42 |
|
|
2022
Q3 | $41.4M | Buy |
481,149
+283,559
| +144% | +$25.3M | 0.68% | 15 |
|
|
2022
Q2 | $18M | Buy |
197,590
+38,365
| +24% | +$3.4M | 0.3% | 85 |
|
|
2022
Q1 | $13.1M | Buy |
159,225
+9,376
| +6% | +$739K | 0.21% | 110 |
|
|
2021
Q4 | $11.5M | Buy |
149,849
+75,361
| +101% | +$6M | 0.17% | 128 |
|
|
2021
Q3 | $5.59M | Sell |
74,488
-21,412
| -22% | -$1.63M | 0.14% | 149 |
|
|
2021
Q2 | $7.46M | Buy |
95,900
+1,684
| +2% | +$125K | 0.2% | 112 |
|
|
2021
Q1 | $6.93M | Sell |
94,216
-40,209
| -30% | -$2.97M | 0.21% | 109 |
|
|
2020
Q4 | $10.5M | Sell |
134,425
-222,587
| -62% | -$17M | 0.34% | 68 |
|
|
2020
Q3 | $28.3M | Buy |
357,012
+29,136
| +9% | +$2.28M | 0.98% | 13 |
|
|
2020
Q2 | $24.2M | Buy |
327,876
+15,214
| +5% | +$1.15M | 0.95% | 22 |
|
|
2020
Q1 | $23M | Sell |
312,662
-1,087
| -0.3% | -$85.4K | 1.11% | 14 |
|
|
2019
Q4 | $27.2M | Buy |
313,749
+29,899
| +11% | +$2.46M | 1.08% | 12 |
|
|
2019
Q3 | $22.8M | Buy |
283,850
+88,661
| +45% | +$7.11M | 1.01% | 14 |
|
|
2019
Q2 | $15.6M | Buy |
195,189
+22,659
| +13% | +$1.73M | 0.96% | 19 |
|
|
2019
Q1 | $13.7M | Buy |
172,530
+127,884
| +286% | +$9.56M | 0.88% | 22 |
|
|
2018
Q4 | $3.25K | Buy |
44,646
+1,640
| +4% | +$116K | 0.21% | 107 |
|
|
2018
Q3 | $2.91M | Buy |
43,006
+3,247
| +8% | +$207K | 0.22% | 108 |
|
|
2018
Q2 | $2.29K | Buy |
39,759
+6,697
| +20% | +$378K | 0.21% | 111 |
|
|
2018
Q1 | $1.68M | Buy |
33,062
+4,148
| +14% | +$224K | 0.19% | 118 |
|
|
2017
Q4 | $1.56M | Buy |
28,914
+43
| +0.1% | +$2.38K | 0.21% | 109 |
|
|
2017
Q3 | $1.77M | Sell |
28,871
-574
| -2% | -$34.8K | 0.28% | 89 |
|
|
2017
Q2 | $1.77M | Buy |
29,445
+8,119
| +38% | +$494K | 0.3% | 80 |
|
|
2017
Q1 | $1.29M | Sell |
21,326
-6,825
| -24% | -$414K | 0.29% | 83 |
|
|
2016
Q4 | $1.65M | Buy |
28,151
+16,641
| +145% | +$974K | 0.46% | 58 |
|
|
2016
Q3 | $687K | Buy |
11,510
+4,900
| +74% | +$287K | 0.22% | 96 |
|
|
2016
Q2 | $363K | Buy |
+6,610
| New | +$352K | 0.15% | 116 |
|
Other funds holding MRK
VCM
VPM
NewEdge Advisors's MRK Position: Q1 2026 in Review
NewEdge Advisors increased its Merck (MRK) stake by 4.3% in Q1 2026, buying an estimated $1.98M and bringing the position to 413,565 shares worth $49.7M. The position accounts for 0.18% of the portfolio, ranked #118.
NewEdge Advisors first reported a position in MRK in Q2 2016 and has held it in 40 quarters since. The position peaked at $81.2M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- NewEdge Advisors held 413,565 shares of Merck worth $49.7M as of Q1 2026.
- NewEdge Advisors bought 17,134 Merck shares in Q1 2026, an estimated $1.98M.
- Merck made up 0.18% of NewEdge Advisors's portfolio in Q1 2026, its #118 holding.
- NewEdge Advisors first reported a position in Merck in Q2 2016 and has held it in 40 quarters since.
- NewEdge Advisors's Merck position peaked at $81.2M in Q2 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.